Lactobacillus casei and application thereof in preparation of irritable bowel syndrome medicine
The invention provides lactobacillus casei and application of the lactobacillus casei in preparation of drugs for treating irritable bowel syndrome. The preservation number of the lactobacillus casei is CGMCC No.26343. Compared with common lactobacillus casei, the lactobacillus casei strain has very strong bacteriostatic ability to pathogenic bacteria, and has outstanding colonic mucosa epithelial cell viscosity at the same time. According to the present invention, the intestinal antibacterial drug prepared from the compound can be used for treatment of a variety of bacterial intestinal diseases; the composition has a remarkable effect on bacterial intestinal diseases, is safe and non-toxic, has good stability and can be stored at normal temperature..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 10. Nov. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
LI YULONG [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-11-10, Last update posted on www.tib.eu: 2024-04-29, Last updated: 2024-05-03 |
|---|
| Patentnummer: |
CN117025448 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA004157265 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA004157265 | ||
| 003 | DE-627 | ||
| 005 | 20240503111627.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240503s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA004157265 | ||
| 035 | |a (EPA)CN117025448 | ||
| 035 | |a (EPA)88638007 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a LI YULONG |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Lactobacillus casei and application thereof in preparation of irritable bowel syndrome medicine |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-11-10, Last update posted on www.tib.eu: 2024-04-29, Last updated: 2024-05-03 | ||
| 520 | |a The invention provides lactobacillus casei and application of the lactobacillus casei in preparation of drugs for treating irritable bowel syndrome. The preservation number of the lactobacillus casei is CGMCC No.26343. Compared with common lactobacillus casei, the lactobacillus casei strain has very strong bacteriostatic ability to pathogenic bacteria, and has outstanding colonic mucosa epithelial cell viscosity at the same time. According to the present invention, the intestinal antibacterial drug prepared from the compound can be used for treatment of a variety of bacterial intestinal diseases; the composition has a remarkable effect on bacterial intestinal diseases, is safe and non-toxic, has good stability and can be stored at normal temperature. | ||
| 650 | 4 | |a bio | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a C12R: Indexing scheme associated with subclasses c12c-c12q, relating to microorganisms | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a ZHANG YI |e verfasserin |4 aut | |
| 700 | 0 | |a XU FENGLIAN |e verfasserin |4 aut | |
| 700 | 0 | |a XU RUIPENG |e verfasserin |4 aut | |
| 700 | 0 | |a CHEN GUIHAO |e verfasserin |4 aut | |
| 700 | 0 | |a XU SHAOYAN |e verfasserin |4 aut | |
| 700 | 0 | |a ZHANG JIADONG |e verfasserin |4 aut | |
| 700 | 0 | |a XU XIAOHUANG |e verfasserin |4 aut | |
| 700 | 0 | |a CHEN ZERONG |e verfasserin |4 aut | |
| 700 | 0 | |a HUANG XUPAN |e verfasserin |4 aut | |
| 700 | 0 | |a CHEN SHAOXIONG |e verfasserin |4 aut | |
| 700 | 0 | |a LIN RUIJIE |e verfasserin |4 aut | |
| 700 | 0 | |a LIN SHUFEI |e verfasserin |4 aut | |
| 700 | 0 | |a SU XUE |e verfasserin |4 aut | |
| 700 | 0 | |a ZHANG CHAOHUI |e verfasserin |4 aut | |
| 700 | 0 | |a ZHENG XUE'ER |e verfasserin |4 aut | |
| 700 | 0 | |a ZHANG BOBO |e verfasserin |4 aut | |
| 700 | 0 | |a GONG LI |e verfasserin |4 aut | |
| 700 | 0 | |a FANG WEIRONG |e verfasserin |4 aut | |
| 700 | 0 | |a LI GUILONG |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 10. Nov. |
| 773 | 1 | 8 | |g year:2023 |g day:10 |g month:11 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/88638007/publication/CN117025448A1?q=CN117025448 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 10 |c 11 | ||